The FDA has extended its review of a new subcutaneous formulation of Sanofi's multiple myeloma therapy Sarclisa – which has ...

Roche has said its oral BTK inhibitor fenebrutinib could become the first drug in the class to be approved for multiple ...

The first volunteers in a large-scale trial of Moderna's mRNA-based vaccine against bird flu – long considered to be a ...

Too many patient access strategies stop at “script filled”. But this approach is ultimately short-sighted, failing to build ...

The Trump administration has extended the duration of a pilot programme to provide access to obesity drugs through Medicare, ...

In the pharmaceutical and healthcare sectors, where precision is paramount and human lives are directly impacted, these ...

Novo Nordisk acquired rights to etavopivat when it bought Forma Therapeutics for $1.1 billion in 2022, when the drug was in ...

A combination regimen for kidney cancer treatment based on MSD's Welireg has failed a phase 3 trial, denting the company's ...

After years of constrained capital markets, biotech companies are operating in an environment where even late-stage ...

Preeclampsia is a serious pregnancy disorder, affecting nearly 10 millionwomen globally each year, and can strike without ...

Jazz Pharma's Ziihera and Eli Lilly's Jaypirca, respectively – have been recommended by reimbursement agency NICE for NHS use ...

Roche could be just months away from an FDA approval of Gazyva as the first anti-CD20 therapy for systemic lupus ...